Invention Grant
- Patent Title: Recombinant allergen
-
Application No.: US13772046Application Date: 2013-02-20
-
Publication No.: US09657070B2Publication Date: 2017-05-23
- Inventor: Hans Gronlund , Marianne van Hage
- Applicant: ALK-Abello A/S
- Applicant Address: DK Horsholm
- Assignee: ALK-ABELLO A/S
- Current Assignee: ALK-ABELLO A/S
- Current Assignee Address: DK Horsholm
- Agency: Womble Carlyle Sandridge & Rice LLP
- Priority: GB0309345.7 20030424
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/35 ; A61K39/36 ; C07K1/00 ; C07K14/00 ; C07K17/00 ; C07K14/47

Abstract:
Dander from the domestic cat (Felis domesticus) is one of the most common causes of IgE mediated allergy. The present invention relates to a recombinant folded Fel d 1 with molecular and biological properties similar to the natural counterpart and specifically a synthetic gene coding for a direct fusion of Fel d 1 chain 2 N-terminally to chain 1. E coli expression resulted in a non-covalently associated homodimer with an apparent molecular weight of 30 kDa defined by size exclusion chromatography, each 19177 Da subunit displayed a disulfide pattern identical to that found in the natural Fel d 1, and having identical fold of natural and recombinant Fel d 1. The, recombinant Fel d 1 provides for diagnosis and allergen specific immunotherapy of cat allergy.
Public/Granted literature
- US20130195902A1 RECOMBINANT ALLERGEN Public/Granted day:2013-08-01
Information query